Legal & General Group
BDTX icon

Legal & General Group’s Black Diamond Therapeutics BDTX Stock Holding History

Legal & General Group’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.44K Buy
+4,564
New +$11.2K ﹤0.01% 3336
2025
Q2 		– Sell
-3,825
Closed -$5.93K – 3431
2025
Q1 		$5.93K Hold
3,825
– – ﹤0.01% 3253
2024
Q4 		$8.19K Hold
3,825
– – ﹤0.01% 3287
2024
Q3 		$16.6K Hold
3,825
– – ﹤0.01% 3120
2024
Q2 		$17.7K Buy
+3,825
New +$20.5K ﹤0.01% 3071
2022
Q2 		– Sell
-1,815
Closed -$5K – 3534
2022
Q1 		$5K Hold
1,815
– – ﹤0.01% 3500
2021
Q4 		$10K Sell
1,815
-4,653
-72% -$32.5K ﹤0.01% 3458
2021
Q3 		$54K Buy
6,468
+4,269
+194% +$42.2K ﹤0.01% 2954
2021
Q2 		$27K Sell
2,199
-786
-26% -$15.5K ﹤0.01% 3171
2021
Q1 		$72K Buy
2,985
+446
+18% +$12K ﹤0.01% 2706
2020
Q4 		$81K Hold
2,539
– – ﹤0.01% 2643
2020
Q3 		$77K Buy
2,539
+165
+7% +$5.02K ﹤0.01% 2563
2020
Q2 		$100K Buy
2,374
+504
+27% +$18.5K ﹤0.01% 2533
2020
Q1 		$45K Buy
+1,870
New +$56.9K ﹤0.01% 2619

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Legal & General Group's BDTX Position: Q2 2026 in Review

Legal & General Group opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 4,564 shares worth $8.44K. The stake represents ﹤0.01% of the portfolio and ranks #3336 among its holdings. This is a return to the name: Legal & General Group previously reported a position in BDTX as recently as Q1 2025.

Legal & General Group first reported a position in BDTX in Q1 2020 and has held it in 14 quarters since. The position peaked at $100K in Q2 2020. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Legal & General Group held 4,564 shares of Black Diamond Therapeutics worth $8.44K as of Q2 2026.
  • Black Diamond Therapeutics was a new Legal & General Group position in Q2 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3336 holding.
  • Legal & General Group first reported a position in Black Diamond Therapeutics in Q1 2020 and has held it in 14 quarters since.
  • Legal & General Group's Black Diamond Therapeutics position peaked at $100K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.